4.5 Article

Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study

期刊

HYPERTENSION RESEARCH
卷 44, 期 7, 页码 813-821

出版社

SPRINGERNATURE
DOI: 10.1038/s41440-021-00629-x

关键词

Japan; Predictive performance; Preeclampsia; Prognosis; Soluble fms-like tyrosine kinase 1; placental growth factor ratio

资金

  1. Roche Diagnostics International Ltd (Rotkreuz, Switzerland)

向作者/读者索取更多资源

The subanalysis of Japanese women with suspected preeclampsia showed a high predictive value of Elecsys sFlt-1/PlGF ratio cutoff of 38 for short-term prediction of preeclampsia. This ratio can effectively rule out or diagnose preeclampsia within 1 week, helping to accurately determine the condition of pregnant women.
Two prospective multicenter studies demonstrated that a soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio cutoff of <= 38 can rule out preeclampsia within 1 week with a negative predictive value (NPV) of 99.3% (PROGNOSIS) and 98.6% (PROGNOSIS Asia). We report a subanalysis of the Japanese cohort from the PROGNOSIS Asia study. Pregnant women with suspected preeclampsia between gestational weeks 18 + 0 days and 36 + 6 days were enrolled at eight Japanese sites. Primary objectives: Assess the performance of the Elecsys(R) sFlt-1/PlGF ratio cutoff <= 38 to rule out preeclampsia within 1 week and of the cutoff >38 to rule in preeclampsia within 4 weeks. Key secondary objectives: Prediction of maternal and fetal adverse outcomes (MAOs/FAOs) and their relationship with duration of pregnancy. Of 192 women enrolled, 180 (93.8%)/175 (91.1%) were evaluable for primary/combined endpoint analyses. Overall preeclampsia prevalence was 13.3%. A sFlt-1/PlGF ratio of <= 38 provided an NPV of 100% (95% confidence interval [CI], 97.5-100) for ruling out preeclampsia within 1 week, and a ratio of >38 provided a positive predictive value of 32.4% (95% CI, 18.0-49.8) for ruling in preeclampsia within 4 weeks. The area under the curve for the prediction of preeclampsia/maternal/fetal adverse outcomes within 1 week was 94.2% (95% CI, 89.3-97.8). After adjusting for gestational age and final preeclampsia status, Cox regression indicated a 2.8-fold greater risk of imminent delivery for women with a sFlt-1/PlGF ratio >38 versus <= 38. This subanalysis of Japanese women with suspicion of preeclampsia showed high predictive value for a Elecsys sFlt-1/PlGF ratio cutoff of 38 for short-term prediction of preeclampsia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

A randomized phase 3 trial evaluating antithrombin gamma treatment in Japanese patients with early-onset severe preeclampsia (KOUNO-TORI study): Study protocol

Shigeru Saito, Kenichi Takagi, Junji Moriya, Takao Kobayashi, Naohiro Kanayama, Hiroshi Sameshima, Mamoru Morikawa, Haruhiko Sago, Tomoko Adachi, Akihide Ohkuchi, Satoru Takeda, Hisashi Masuyama, Hiroyuki Seki

Summary: This study protocol aims to evaluate the efficacy of recombinant human antithrombin gamma in treating early-onset severe de novo preeclampsia. By selecting a specifically defined target population based on reanalysis of previous data, the study is expected to provide valuable efficacy and safety data for Japanese patients.

CONTEMPORARY CLINICAL TRIALS (2021)

Article Peripheral Vascular Disease

Elevated S100A9 in preeclampsia induces soluble endoglin and IL-1β secretion and hypertension via the NLRP3 inflammasome

Ayae Ozeki, Yuka Oogaki, Yuka Henmi, Tadayoshi Karasawa, Masafumi Takahashi, Hironori Takahashi, Akihide Ohkuchi, Koumei Shirasuna

Summary: This study found that S100A9 is associated with the pathogenesis of hypertensive disorders of pregnancy and can activate the NLRP3 inflammasome. Animal experiments also confirmed that injection of S100A9 can cause hypertension and neutrophil accumulation in pregnant mice.

JOURNAL OF HYPERTENSION (2022)

Article Obstetrics & Gynecology

Effects of prophylactic vaginal progesterone administration on mild cervical shortening (TROPICAL study): a multicenter, double-blind, randomized trial

Masako Hayashi, Rie Oi, Katsufumi Otsuki, Noriko Yoneda, Takeshi Nagamatsu, Ryota Kumasaka, Kei Miyakoshi, Hiroaki Aoki, Kei Tanaka, Kazumasa Kumazawa, Akihide Ohkuchi, Yoshio Matsuda, Akihito Nakai

Summary: Vaginal progesterone reduces preterm birth rates among women with mild cervical shortening, despite not preserving cervical length; expanding progesterone treatment indications to include both high-risk and low-risk populations may be beneficial.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Article Obstetrics & Gynecology

Long-term outcome of fetus with ameliorated cystic hygroma

Keiko Kagawa, Hironori Takahashi, Shiho Nagayama, Kenji Horie, Kayo Takahashi, Yosuke Baba, Manabu Ogoyama, Hirotada Suzuki, Rie Usui, Akihide Ohkuchi, Shigeki Matsubara

Summary: This study investigated the short/long-term outcomes of fetuses/neonates with ameliorated cystic hygroma during pregnancy and found that half of them had good outcomes while the other half had abnormalities. Fetuses with a nuchal thickness >5mm at diagnosis may be more likely to have abnormalities.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2021)

Article Obstetrics & Gynecology

Retained products of conception in placenta previa without placenta accreta spectrum: who requires transarterial embolization and/or hysterectomy?

Mai Ohashi, Hironori Takahashi, Yosuke Baba, Hirotada Suzuki, Shiho Nagayama, Kenji Horie, Manabu Ogoyama, Rie Usui, Akihide Ohkuchi, Shigeki Matsubara

Summary: This study focused on patients with retained products of conception in placenta previa and found that patients with hypervascular RPOC and higher bleeding episodes during cesarean section were more likely to require transarterial embolization and/or hysterectomy after cesarean section.

CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY (2022)

Article Obstetrics & Gynecology

Hemostatic effect of combined procedures for placenta previa: cervix-holding, intrauterine balloon, and uterine compression suture

Hironori Takahashi, Yosuke Baba, Rie Usui, Hirotada Suzuki, Kenji Horie, Hitoshi Yano, Akihide Ohkuchi, Shigeki Matsubara

Summary: The combination of MT-holding, IUB, and UCS in patients with placenta previa has been shown to significantly reduce postpartum hemorrhage and the need for blood transfusion. Further studies are needed to determine the best combination of hemostatic procedures for placenta previa.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Article Obstetrics & Gynecology

Bleeding-related outcomes of low-risk total placenta previa are to those of

Manabu Ogoyama, Hironori Takahashi, Yosuke Baba, Hiromichi Yamamoto, Kenji Horie, Shiho Nagayama, Hirotada Suzuki, Rie Usui, Akihide Ohkuchi, Shigeki Matsubara, Hiroyuki Fujiwara

Summary: This study aimed to investigate whether low-risk total placenta previa (PP) patients bleed more than partial/marginal PP patients. The results showed that prior cesarean section (CS), anterior placenta, and placental lacunae on ultrasound were risk factors for bleeding-related poor outcomes in total PP patients. However, low-risk total PP patients without these three factors had similar bleeding-related poor outcomes as partial/marginal PP patients.

TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2022)

Review Cell Biology

Non-Coding RNAs and Prediction of Preeclampsia in the First Trimester of Pregnancy

Manabu Ogoyama, Hironori Takahashi, Hirotada Suzuki, Akihide Ohkuchi, Hiroyuki Fujiwara, Toshihiro Takizawa

Summary: Preeclampsia (PE) is a dangerous condition with challenges in treatment and prevention. Research suggests that identifying maternal circulating non-coding RNAs (ncRNAs) in early pregnancy may help predict the development of PE.
Article Peripheral Vascular Disease

Exponential increase of the gestational-age-specific incidence of preeclampsia onset (COPE study): a multicenter retrospective cohort study in women with maternal check-ups at <20 weeks of gestation in Japan

Akihide Ohkuchi, Hirotada Suzuki, Keiichi Matsubara, Kazushi Watanabe, Takuya Saitou, Hideyuki Oda, Soichiro Obata, Shinya Kondo, Kiyoshi Noda, Junya Miyoshi, Satoru Ikenoue, Makoto Nomiyama, Hiroyuki Seki, Sachi Sukegawa, Satoshi Ichigo, Hirofumi Ando, Chiho Fuseya, Takuya Shimomura, Rika Suzuki, Kazuya Mimura, Ichiro Yasuhi, Masashi Fukuda, Sumiko Hara, Ryuhei Kurashina, Arihiro Shiozaki, Shigeki Matsubara, Shigeru Saito

Summary: This study investigated whether there were dual peaks in the gestational-age-specific incidence or prevalence of early-onset preeclampsia, and concluded that there were no dual peaks, refuting the previous rationale of defining early-onset preeclampsia as occurring before 32 weeks of gestation.

HYPERTENSION RESEARCH (2022)

Article Obstetrics & Gynecology

Uterine contraction may not be an independent risk factor for spontaneous preterm birth before 35 weeks in women with cervical shortening

Kenji Horie, Kayo Takahashi, Makiko Mieno, Shiho Nagayama, Hiroaki Aoki, Takeshi Nagamatsu, Ayumi Kanatani, Hironobu Hyodo, Kayoko Terada, Masako Hayashi, Akihito Nakai, Noriko Yoneda, Shigeru Saito, Yoshio Matsuda, Shigeki Matsubara, Akihide Ohkuchi

Summary: This study compared the risk of spontaneous preterm birth (SPTB) before 35 weeks in symptomatic and asymptomatic women with cervical shortening at 16-34 weeks under mid-trimester universal screening of cervical length (CL). The results showed that the presence of uterine contractions at admission may not be an independent risk factor for the occurrence of SPTB before 35 weeks, while CL of 1-9 mm, CL of 10-14 mm, and vaginal bleeding at admission were identified as independent risk factors for SPTB before 35 weeks.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

Article Obstetrics & Gynecology

Prevalence of chronic hypertension and white coat hypertension in women presenting with at least one hypertension level on two to three consecutive measurements in a clinical setting at <20 weeks of gestation (JP-WCH1 study): A multicenter prospective cohort study

Chikako Hirashima, Kazuya Mimura, Takako Ohmaru-Nakanishi, Kohei Kotera, Kayo Takahashi, Shigeru Saito, Hiroyuki Seki, Kazushi Watanabe, Katsuhiko Naruse, Shintaro Makino, Hirohito Metoki, Shigeki Matsubara, Atsuhiro Ichihara, Akihide Ohkuchi

Summary: This study aimed to investigate the prevalence of chronic hypertension, white coat hypertension, and masked hypertension in pregnant women at <20 weeks of gestation. The results showed that the prevalence of chronic hypertension, white coat hypertension, and masked hypertension were 11%, 30%, and 2% respectively. The incidence of preeclampsia in women with chronic hypertension was 20%, and the incidence of gestational hypertension and preeclampsia in women with white coat hypertension were 0% and 17% respectively.

HYPERTENSION RESEARCH IN PREGNANCY (2022)

Meeting Abstract Developmental Biology

STRUCTURAL CHARACTERISTICS OF EXOSOMES AND NANOPARTICLES DERIVED FROM TROPHOBLAST CELL LINE BEWO

Shohei Tozawa, Syunya Noguchi, Takanobu Sakurai, Akihide Ohkuchi, Hironori Takahashi, Hiroyuki Fujiwara, Toshihiro Takizawa

PLACENTA (2022)

Meeting Abstract Developmental Biology

EXAMINATION OF THE ROLE OF INFLAMMATION-RELATED FACTOR S100A9 IN HYPERTENSIVE DISORDERS OF PREGNANCY

Airi Hirooka, Yuka Oogaki, Ayae Ozeki, Hironori Takahashi, Akihide Ohkuchi, Koumei Shirasuna

PLACENTA (2021)

Meeting Abstract Developmental Biology

IN SILICO ANALYSIS AND EXPRESSION ANALYSIS OF HUMAN PLACENTAL LONG NON-CODING RNAS

Manabu Ogoyama, Junxiao Wang, Dongwei Zhao, Hironori Takahashi, Shigeki Matsubara, Akihide Ohkuchi, Toshihiro Takizawa

PLACENTA (2021)

暂无数据